On January 14, 2019, Zomedica Pharmaceuticals Corp. (TSXV:ZOM) closed the transaction. The company has issued 49,342 shares for gross proceeds of $74,999.84 in the its second tranche. All securities issued in the tranche will expire on May 12, 2019. The TSX Venture Exchange has accepted for filing documentation with respect to the transaction. The transaction involved participation from 2 placees.